explore -WSS

explore

author：focus 2025-09-06 04:14:09 - browse：9337

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Court strikes down limits on filming of police in Arizona

WSS

Organ transplantation is at a crossroads. Major reform is needed

Death toll from an explosion and collapse of a Paris building in June climbs to 3

Congenital heart disease patients face new threat of heart failure

Leukemia patients are helped by Syndax's new type of therapy

AI models in health care face new federal disclosure requirements

Pregnancy discrimination could be enabled by AI

explore

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Drug repurposing or repositioning? The language matters

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Heart attack and stroke risk calculators need revising

Why an extreme heat and wildfire smoke combination can be so dangerous

Bright Health sells Medicare Advantage business to Molina

Pfizer plans to depart BIO

Medicare details structure of new drug price negotiation program

The woman behind the Dana Farber

New air purifier tech could be key to improving indoor air quality

CMS should re

focus

Artificial intelligence advances fuel industry trying to preserve loved ones after death

What to know about Saharan dust affecting the US and how it can affect health

Roche to buy Carmot Therapeutics, developer of obesity drugs

Why sickle cell disease is getting the first CRISPR treatment

Americans' trust in science, scientist continues decline: Report

Our daughter's deadly disease: trisomy 18. We wanted to protect her

knowledge

entertainment

entertainment

focus